Thursday 20 July 2023, 6.00-7.00pm
Room 203 Melbourne Convention and Exhibition Centre
DNA screening for risk of disease that can be prevented or treated (like some cancers or heart disease) is being offered to 10,000 Australians (18-40yo) though the DNA Screen pilot study. This testing could save lives, but there are many ethical and societal issues to consider. Are Australians ready for this kind of testing? Would you take the test? What are the benefits? What are the drawbacks? How does this compare to international approaches? Attendees at this exciting event learnt about cutting-edge research, informing the future of population DNA screening.
Assoc. Prof Paul Lacaze (Monash University) - a pioneering leader in public health genomics and population DNA screening. He is the Project Leader of DNA Screen. | |
Dr Jane Tiller (Monash University) - a lawyer and genetic counsellor and has a keen interest in the ethical and legal aspects of genomics and public health | |
Professor Nancy Cox (Vanderbilt University, USA) - Director of the Vanderbilt Genetics Institute and Director of the Division of Genetic Medicine. |
©2018 International Congress of Genetics 2023